It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Studies using machine learning (ML) approaches have reported high diagnostic accuracies for glaucoma detection. However, none assessed model performance across ethnicities. The aim of the study is to externally validate ML models for glaucoma detection from optical coherence tomography (OCT) data. We performed a prospective, cross-sectional study, where 514 Asians (257 glaucoma/257 controls) were enrolled to construct ML models for glaucoma detection, which was then tested on 356 Asians (183 glaucoma/173 controls) and 138 Caucasians (57 glaucoma/81 controls). We used the retinal nerve fibre layer (RNFL) thickness values produced by the compensation model, which is a multiple regression model fitted on healthy subjects that corrects the RNFL profile for anatomical factors and the original OCT data (measured) to build two classifiers, respectively. Both the ML models (area under the receiver operating [AUC] = 0.96 and accuracy = 92%) outperformed the measured data (AUC = 0.93; P < 0.001) for glaucoma detection in the Asian dataset. However, in the Caucasian dataset, the ML model trained with compensated data (AUC = 0.93 and accuracy = 84%) outperformed the ML model trained with original data (AUC = 0.83 and accuracy = 79%; P < 0.001) and measured data (AUC = 0.82; P < 0.001) for glaucoma detection. The performance with the ML model trained on measured data showed poor reproducibility across different datasets, whereas the performance of the compensated data was maintained. Care must be taken when ML models are applied to patient cohorts of different ethnicities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Nanyang Technological University, School of Computer Science and Engineering, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361)
2 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Duke-NUS Medical School, Ophthalmology & Visual Sciences Academic Clinical Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); SERI-NTU Advanced Ocular Engineering (STANCE), Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670)
3 Medical University Vienna, Center for Medical Statistics Informatics and Intelligent Systems, Section for Medical Information Management, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492); Medical University Vienna, Department of Clinical Pharmacology, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)
4 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Duke-NUS Medical School, Ophthalmology & Visual Sciences Academic Clinical Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924)
5 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Duke-NUS Medical School, Ophthalmology & Visual Sciences Academic Clinical Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland (GRID:grid.508836.0)
6 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711)
7 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Duke-NUS Medical School, Ophthalmology & Visual Sciences Academic Clinical Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); Yong Loo Lin School of Medicine, National University of Singapore, Department of Ophthalmology, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431)
8 Medical University Vienna, Center for Medical Statistics Informatics and Intelligent Systems, Section for Medical Information Management, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)
9 Medical University Vienna, Department of Ophthalmology and Optometry, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)
10 Carol Davila University of Medicine and Pharmacy, Bucharest, Romania (GRID:grid.8194.4) (ISNI:0000 0000 9828 7548)
11 Nanyang Technological University, School of Computer Science and Engineering, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361)
12 Carol Davila University of Medicine and Pharmacy, Bucharest, Romania (GRID:grid.8194.4) (ISNI:0000 0000 9828 7548); Emergency University Hospital, Department of Ophthalmology, Bucharest, Romania (GRID:grid.412152.1) (ISNI:0000 0004 0518 8882)
13 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); Duke-NUS Medical School, Ophthalmology & Visual Sciences Academic Clinical Program, Singapore, Singapore (GRID:grid.428397.3) (ISNI:0000 0004 0385 0924); SERI-NTU Advanced Ocular Engineering (STANCE), Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Medical University Vienna, Department of Clinical Pharmacology, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492); Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland (GRID:grid.508836.0); Nanyang Technological University, School of Chemical and Biomedical Engineering, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361); Medical University Vienna, Center for Medical Physics and Biomedical Engineering, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)
14 Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore (GRID:grid.419272.b) (ISNI:0000 0000 9960 1711); SERI-NTU Advanced Ocular Engineering (STANCE), Singapore, Singapore (GRID:grid.272555.2) (ISNI:0000 0001 0706 4670); Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland (GRID:grid.508836.0); Nanyang Technological University, School of Chemical and Biomedical Engineering, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361)